Evidence map›Paper›PMID 37369978›Full record

ReviewJournal of epidemiology and global health2023

Lessons Learned from Sudan Ebola Virus Disease (SUDV) Preparedness in Rwanda: A Comprehensive Review and Way Forward.

Edson Rwagasore, Olivier Nsekuye, Ziad El-Khatib, Adeline Kabeja, Valois H Mucunguzi, Pacifique Nizeyimana, Edward Ruseesa, Laurent Ruyange, Isabelle B Teta, Sandrine Uwamahoro and 12 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of epidemiology and global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 2 countries.

Edson RwagasorePublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda. rwagasoredson@gmail.com.ORCID 0009-0006-5002-0829
Olivier NsekuyePublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Ziad El-KhatibDepartment of Global Public Health, Karolinska Institutet, 17177, Solna, Sweden. ziad.khatib@gmail.com.
Adeline KabejaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Valois H MucunguziPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Pacifique NizeyimanaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Edward RuseesaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Laurent RuyangePublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Isabelle B TetaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Sandrine UwamahoroPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Solange TwahirwaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Denyse MugawanezaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Leandre IshemaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Hugor ShemaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Alfred RutagengwaWorld Health Organization Rwanda Country Office, P.O. Box 1324, Kigali, Rwanda.
Valens NdagijimanaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Ines ItangaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Alexis KapiteniPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Jean Luc BenimanaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Jean Claude NiyoyitaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Bruce RwagitinywaPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Claude Mambo MuvunyiPublic Health Surveillance, Emergency Preparedness and Response Division (PHS&EPR), Rwanda Biomedical Center (RBC), P.O. Box 7162, Kigali, Rwanda.
Rwanda Biomedical Center · RWKarolinska Institutet · SE

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundEbola Virus Disease (EVD) is a severe and often fatal illness that affects humans and has significant public health implications, including high mortality rates, strain on healthcare systems, and social and economic disruption. On 20 September 2022, Uganda declared an Ebola disease outbreak caused by the Sudan ebolavirus species. The neighboring countries of Uganda were classified by World Health Organization (WHO) as being at high risk of Sudan Ebola Virus Disease (SUDV) importation. The country of Rwanda implemented different sustainable strategies and activities to prepare and ensure a timely and effective response to SUDV outbreaks once it has arrived in the country. We aimed to highlight the sustainable strategies and activities implemented for SUDV preparedness and the subsequent lessons learnt in Rwanda.

methodsThis paper reviewed the documentation on activities implemented for SUDV preparedness, with a focus on lessons learned from different countries. The paper analyzed the common themes and highlighted the key components of EVD preparedness in Rwanda after declaration of SUDV outbreak in Uganda.

resultsThe key components of SUDV preparedness include its readiness assessment in Rwanda, effective coordination, collaboration and leadership mechanisms, enhancing the early detection and surveillance system, effective risk communication and community engagement, capacity building of healthcare providers on case management and infection prevention and control (IPC), and continual preparedness. These components were essential to ensure timely and effective preparation and response to SUDV related outbreaks.

conclusionA multi-sectoral approach involving all stakeholders was necessary to ensure timely and effective preparation and response. Continuous investment in preparedness, strengthening of health systems, and the review of preparedness components provided insights into the best practices for SUDV preparedness, which were essential to prevent future outbreaks and minimize their impact. This will inform other countries about the role of timely development of preparedness plans.

Indexed as

EbolavirusHemorrhagic Fever, EbolaDisease OutbreaksHumansRwandaSudanLessons learnedPreparednessRwandaSudan Ebola virus disease

Identifiers

PMID37369978
PMCPMC10469131
OpenAlexW4382344818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.